An interventional study of Ear-worn prototype devices in Hearing Loss and Well Aging, sponsored by 57GGardner. Completed at 1 site in United States. Open to participants aged 40 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-04.
Sponsored by 57GGardner · Not applicable, Interventional, and Other
This study incorporates data collection to aid in development of software features related to physical activity for users of ear-worn devices.
This exploratory study involves data collection of adults performing physical activities and activities of daily living for the purpose of comparing data collected by the ear-worn device under test and established gold standard/reference devices and consumer electronic devices. Data collected will be used in the development of software features related to physical activities to benefit the experience of ear-worn device users.
1,092 studies on the registry are indexed under Hearing Loss; 235 are open to participants now.
This study's enrollment of 30 is below the median of 40 across 764 interventional studies indexed under Hearing Loss.
Browse Hearing Loss studies →This is the only study on the registry with 57GGardner as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
A cohort of physically-active adults will use ear-worn prototype devices and established gold standard and comparator devices during rest periods, physical activity, and various activities of daily living.
Device: Ear-worn prototype devices
Hearing instrument including sensors to track movement and estimations of biological information.
Also known as: Phonak Audeo
Accuracy of ear-worn device information
Accuracy of information provided by the ear-worn device in comparison to the comparator devices using mean absolute percentage error calculations
Time frame: data collection during activities ranging in duration from 5-20 minutes
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.